Global Biosimilar of Remicade Market 2022 by Company, Regions, Type and Application, Forecast to 2028 - Market Study Report

Global Biosimilar of Remicade Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Format: PDF | Report ID: 5436361 | Published Date: August 06, 2022

Choose License
The Biosimilar of Remicade market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biosimilar of Remicade market size is estimated to be worth US$ 307660 million in 2021 and is forecast to a readjusted size of USD 490500 million by 2028 with a CAGR of 6.9% during review period. Tumor accounting for  % of the Biosimilar of Remicade global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Monoclonal Antibodies segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Biosimilar of Remicade include Roche, Amgen, AbbVie, Sanofi-Aventis, and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Biosimilar of Remicade market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Monoclonal Antibodies
    Interferon
    Erythropoietin
    Insulin
    Vaccines
    Other
Market segment by Application, can be divided into
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Other
Market segment by players, this report covers
    Roche
    Amgen
    AbbVie
    Sanofi-Aventis
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Eli Lilly
    Novartis
    Merck
    3sbio
    Changchun High Tech
    CP Guojian
    Biotech
    Gelgen
    Innovent
    Dong Bao
    Ganlee
    United Laboratories
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biosimilar of Remicade product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosimilar of Remicade, with revenue, gross margin and global market share of Biosimilar of Remicade from 2019 to 2022.
Chapter 3, the Biosimilar of Remicade competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biosimilar of Remicade market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biosimilar of Remicade research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Product Overview and Scope of Biosimilar of Remicade
    1.2 Classification of Biosimilar of Remicade by Type
        1.2.1 Overview: Global Biosimilar of Remicade Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Biosimilar of Remicade Revenue Market Share by Type in 2021
        1.2.3 Monoclonal Antibodies
        1.2.4 Interferon
        1.2.5 Erythropoietin
        1.2.6 Insulin
        1.2.7 Vaccines
        1.2.8 Other
    1.3 Global Biosimilar of Remicade Market by Application
        1.3.1 Overview: Global Biosimilar of Remicade Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Cardiovascular
        1.3.5 Hemophilia
        1.3.6 Other
    1.4 Global Biosimilar of Remicade Market Size & Forecast
    1.5 Global Biosimilar of Remicade Market Size and Forecast by Region
        1.5.1 Global Biosimilar of Remicade Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Biosimilar of Remicade Market Size by Region, (2017-2022)
        1.5.3 North America Biosimilar of Remicade Market Size and Prospect (2017-2028)
        1.5.4 Europe Biosimilar of Remicade Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Biosimilar of Remicade Market Size and Prospect (2017-2028)
        1.5.6 South America Biosimilar of Remicade Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Biosimilar of Remicade Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biosimilar of Remicade Market Drivers
        1.6.2 Biosimilar of Remicade Market Restraints
        1.6.3 Biosimilar of Remicade Trends Analysis
2 Company Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Biosimilar of Remicade Product and Solutions
        2.1.4 Roche Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Roche Recent Developments and Future Plans
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Biosimilar of Remicade Product and Solutions
        2.2.4 Amgen Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Amgen Recent Developments and Future Plans
    2.3 AbbVie
        2.3.1 AbbVie Details
        2.3.2 AbbVie Major Business
        2.3.3 AbbVie Biosimilar of Remicade Product and Solutions
        2.3.4 AbbVie Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 AbbVie Recent Developments and Future Plans
    2.4 Sanofi-Aventis
        2.4.1 Sanofi-Aventis Details
        2.4.2 Sanofi-Aventis Major Business
        2.4.3 Sanofi-Aventis Biosimilar of Remicade Product and Solutions
        2.4.4 Sanofi-Aventis Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Sanofi-Aventis Recent Developments and Future Plans
    2.5 Johnson & Johnson
        2.5.1 Johnson & Johnson Details
        2.5.2 Johnson & Johnson Major Business
        2.5.3 Johnson & Johnson Biosimilar of Remicade Product and Solutions
        2.5.4 Johnson & Johnson Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Johnson & Johnson Recent Developments and Future Plans
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Biosimilar of Remicade Product and Solutions
        2.6.4 Pfizer Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Pfizer Recent Developments and Future Plans
    2.7 Novo Nordisk
        2.7.1 Novo Nordisk Details
        2.7.2 Novo Nordisk Major Business
        2.7.3 Novo Nordisk Biosimilar of Remicade Product and Solutions
        2.7.4 Novo Nordisk Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Novo Nordisk Recent Developments and Future Plans
    2.8 Eli Lilly
        2.8.1 Eli Lilly Details
        2.8.2 Eli Lilly Major Business
        2.8.3 Eli Lilly Biosimilar of Remicade Product and Solutions
        2.8.4 Eli Lilly Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Eli Lilly Recent Developments and Future Plans
    2.9 Novartis
        2.9.1 Novartis Details
        2.9.2 Novartis Major Business
        2.9.3 Novartis Biosimilar of Remicade Product and Solutions
        2.9.4 Novartis Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Novartis Recent Developments and Future Plans
    2.10 Merck 
        2.10.1 Merck Details
        2.10.2 Merck Major Business
        2.10.3 Merck Biosimilar of Remicade Product and Solutions
        2.10.4 Merck Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Merck Recent Developments and Future Plans
    2.11 3sbio
        2.11.1 3sbio Details
        2.11.2 3sbio Major Business
        2.11.3 3sbio Biosimilar of Remicade Product and Solutions
        2.11.4 3sbio Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 3sbio Recent Developments and Future Plans
    2.12 Changchun High Tech
        2.12.1 Changchun High Tech Details
        2.12.2 Changchun High Tech Major Business
        2.12.3 Changchun High Tech Biosimilar of Remicade Product and Solutions
        2.12.4 Changchun High Tech Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Changchun High Tech Recent Developments and Future Plans
    2.13 CP Guojian
        2.13.1 CP Guojian Details
        2.13.2 CP Guojian Major Business
        2.13.3 CP Guojian Biosimilar of Remicade Product and Solutions
        2.13.4 CP Guojian Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 CP Guojian Recent Developments and Future Plans
    2.14 Biotech
        2.14.1 Biotech Details
        2.14.2 Biotech Major Business
        2.14.3 Biotech Biosimilar of Remicade Product and Solutions
        2.14.4 Biotech Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Biotech Recent Developments and Future Plans
    2.15 Gelgen
        2.15.1 Gelgen Details
        2.15.2 Gelgen Major Business
        2.15.3 Gelgen Biosimilar of Remicade Product and Solutions
        2.15.4 Gelgen Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Gelgen Recent Developments and Future Plans
    2.16 Innovent
        2.16.1 Innovent Details
        2.16.2 Innovent Major Business
        2.16.3 Innovent Biosimilar of Remicade Product and Solutions
        2.16.4 Innovent Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Innovent Recent Developments and Future Plans
    2.17 Dong Bao
        2.17.1 Dong Bao Details
        2.17.2 Dong Bao Major Business
        2.17.3 Dong Bao Biosimilar of Remicade Product and Solutions
        2.17.4 Dong Bao Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Dong Bao Recent Developments and Future Plans
    2.18 Ganlee
        2.18.1 Ganlee Details
        2.18.2 Ganlee Major Business
        2.18.3 Ganlee Biosimilar of Remicade Product and Solutions
        2.18.4 Ganlee Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Ganlee Recent Developments and Future Plans
    2.19 United Laboratories
        2.19.1 United Laboratories Details
        2.19.2 United Laboratories Major Business
        2.19.3 United Laboratories Biosimilar of Remicade Product and Solutions
        2.19.4 United Laboratories Biosimilar of Remicade Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.19.5 United Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Biosimilar of Remicade Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Biosimilar of Remicade Players Market Share in 2021
        3.2.2 Top 10 Biosimilar of Remicade Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Biosimilar of Remicade Players Head Office, Products and Services Provided
    3.4 Biosimilar of Remicade Mergers & Acquisitions
    3.5 Biosimilar of Remicade New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Biosimilar of Remicade Revenue and Market Share by Type (2017-2022)
    4.2 Global Biosimilar of Remicade Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Biosimilar of Remicade Revenue Market Share by Application (2017-2022)
    5.2 Global Biosimilar of Remicade Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Biosimilar of Remicade Revenue by Type (2017-2028)
    6.2 North America Biosimilar of Remicade Revenue by Application (2017-2028)
    6.3 North America Biosimilar of Remicade Market Size by Country
        6.3.1 North America Biosimilar of Remicade Revenue by Country (2017-2028)
        6.3.2 United States Biosimilar of Remicade Market Size and Forecast (2017-2028)
        6.3.3 Canada Biosimilar of Remicade Market Size and Forecast (2017-2028)
        6.3.4 Mexico Biosimilar of Remicade Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Biosimilar of Remicade Revenue by Type (2017-2028)
    7.2 Europe Biosimilar of Remicade Revenue by Application (2017-2028)
    7.3 Europe Biosimilar of Remicade Market Size by Country
        7.3.1 Europe Biosimilar of Remicade Revenue by Country (2017-2028)
        7.3.2 Germany Biosimilar of Remicade Market Size and Forecast (2017-2028)
        7.3.3 France Biosimilar of Remicade Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Biosimilar of Remicade Market Size and Forecast (2017-2028)
        7.3.5 Russia Biosimilar of Remicade Market Size and Forecast (2017-2028)
        7.3.6 Italy Biosimilar of Remicade Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Biosimilar of Remicade Revenue by Type (2017-2028)
    8.2 Asia-Pacific Biosimilar of Remicade Revenue by Application (2017-2028)
    8.3 Asia-Pacific Biosimilar of Remicade Market Size by Region
        8.3.1 Asia-Pacific Biosimilar of Remicade Revenue by Region (2017-2028)
        8.3.2 China Biosimilar of Remicade Market Size and Forecast (2017-2028)
        8.3.3 Japan Biosimilar of Remicade Market Size and Forecast (2017-2028)
        8.3.4 South Korea Biosimilar of Remicade Market Size and Forecast (2017-2028)
        8.3.5 India Biosimilar of Remicade Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Biosimilar of Remicade Market Size and Forecast (2017-2028)
        8.3.7 Australia Biosimilar of Remicade Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Biosimilar of Remicade Revenue by Type (2017-2028)
    9.2 South America Biosimilar of Remicade Revenue by Application (2017-2028)
    9.3 South America Biosimilar of Remicade Market Size by Country
        9.3.1 South America Biosimilar of Remicade Revenue by Country (2017-2028)
        9.3.2 Brazil Biosimilar of Remicade Market Size and Forecast (2017-2028)
        9.3.3 Argentina Biosimilar of Remicade Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Biosimilar of Remicade Revenue by Type (2017-2028)
    10.2 Middle East & Africa Biosimilar of Remicade Revenue by Application (2017-2028)
    10.3 Middle East & Africa Biosimilar of Remicade Market Size by Country
        10.3.1 Middle East & Africa Biosimilar of Remicade Revenue by Country (2017-2028)
        10.3.2 Turkey Biosimilar of Remicade Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Biosimilar of Remicade Market Size and Forecast (2017-2028)
        10.3.4 UAE Biosimilar of Remicade Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Biosimilar of Remicade Revenue by Type, (USD Million), 2017 VS 2021 VS 2028 Table 2. Global Biosimilar of Remicade Revenue by Application, (USD Million), 2017 VS 2021 VS 2028 Table 3. Global Market Biosimilar of Remicade Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028) Table 4. Global Biosimilar of Remicade Revenue (USD Million) by Region (2017-2022) Table 5. Global Biosimilar of Remicade Revenue Market Share by Region (2023-2028) Table 6. Roche Corporate Information, Head Office, and Major Competitors Table 7. Roche Major Business Table 8. Roche Biosimilar of Remicade Product and Solutions Table 9. Roche Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 10. Amgen Corporate Information, Head Office, and Major Competitors Table 11. Amgen Major Business Table 12. Amgen Biosimilar of Remicade Product and Solutions Table 13. Amgen Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 14. AbbVie Corporate Information, Head Office, and Major Competitors Table 15. AbbVie Major Business Table 16. AbbVie Biosimilar of Remicade Product and Solutions Table 17. AbbVie Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 18. Sanofi-Aventis Corporate Information, Head Office, and Major Competitors Table 19. Sanofi-Aventis Major Business Table 20. Sanofi-Aventis Biosimilar of Remicade Product and Solutions Table 21. Sanofi-Aventis Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors Table 23. Johnson & Johnson Major Business Table 24. Johnson & Johnson Biosimilar of Remicade Product and Solutions Table 25. Johnson & Johnson Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 26. Pfizer Corporate Information, Head Office, and Major Competitors Table 27. Pfizer Major Business Table 28. Pfizer Biosimilar of Remicade Product and Solutions Table 29. Pfizer Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 30. Novo Nordisk Corporate Information, Head Office, and Major Competitors Table 31. Novo Nordisk Major Business Table 32. Novo Nordisk Biosimilar of Remicade Product and Solutions Table 33. Novo Nordisk Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 34. Eli Lilly Corporate Information, Head Office, and Major Competitors Table 35. Eli Lilly Major Business Table 36. Eli Lilly Biosimilar of Remicade Product and Solutions Table 37. Eli Lilly Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 38. Novartis Corporate Information, Head Office, and Major Competitors Table 39. Novartis Major Business Table 40. Novartis Biosimilar of Remicade Product and Solutions Table 41. Novartis Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 42. Merck Corporate Information, Head Office, and Major Competitors Table 43. Merck Major Business Table 44. Merck Biosimilar of Remicade Product and Solutions Table 45. Merck Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 46. 3sbio Corporate Information, Head Office, and Major Competitors Table 47. 3sbio Major Business Table 48. 3sbio Biosimilar of Remicade Product and Solutions Table 49. 3sbio Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 50. Changchun High Tech Corporate Information, Head Office, and Major Competitors Table 51. Changchun High Tech Major Business Table 52. Changchun High Tech Biosimilar of Remicade Product and Solutions Table 53. Changchun High Tech Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 54. CP Guojian Corporate Information, Head Office, and Major Competitors Table 55. CP Guojian Major Business Table 56. CP Guojian Biosimilar of Remicade Product and Solutions Table 57. CP Guojian Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 58. Biotech Corporate Information, Head Office, and Major Competitors Table 59. Biotech Major Business Table 60. Biotech Biosimilar of Remicade Product and Solutions Table 61. Biotech Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 62. Gelgen Corporate Information, Head Office, and Major Competitors Table 63. Gelgen Major Business Table 64. Gelgen Biosimilar of Remicade Product and Solutions Table 65. Gelgen Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 66. Innovent Corporate Information, Head Office, and Major Competitors Table 67. Innovent Major Business Table 68. Innovent Biosimilar of Remicade Product and Solutions Table 69. Innovent Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 70. Dong Bao Corporate Information, Head Office, and Major Competitors Table 71. Dong Bao Major Business Table 72. Dong Bao Biosimilar of Remicade Product and Solutions Table 73. Dong Bao Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 74. Ganlee Corporate Information, Head Office, and Major Competitors Table 75. Ganlee Major Business Table 76. Ganlee Biosimilar of Remicade Product and Solutions Table 77. Ganlee Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 78. United Laboratories Corporate Information, Head Office, and Major Competitors Table 79. United Laboratories Major Business Table 80. United Laboratories Biosimilar of Remicade Product and Solutions Table 81. United Laboratories Biosimilar of Remicade Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 82. Global Biosimilar of Remicade Revenue (USD Million) by Players (2019, 2020, 2021, and 2022) Table 83. Global Biosimilar of Remicade Revenue Share by Players (2019, 2020, 2021, and 2022) Table 84. Breakdown of Biosimilar of Remicade by Company Type (Tier 1, Tier 2 and Tier 3) Table 85. Biosimilar of Remicade Players Head Office, Products and Services Provided Table 86. Biosimilar of Remicade Mergers & Acquisitions in the Past Five Years Table 87. Biosimilar of Remicade New Entrants and Expansion Plans Table 88. Global Biosimilar of Remicade Revenue (USD Million) by Type (2017-2022) Table 89. Global Biosimilar of Remicade Revenue Share by Type (2017-2022) Table 90. Global Biosimilar of Remicade Revenue Forecast by Type (2023-2028) Table 91. Global Biosimilar of Remicade Revenue by Application (2017-2022) Table 92. Global Biosimilar of Remicade Revenue Forecast by Application (2023-2028) Table 93. North America Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million) Table 94. North America Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million) Table 95. North America Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million) Table 96. North America Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million) Table 97. North America Biosimilar of Remicade Revenue by Country (2017-2022) & (USD Million) Table 98. North America Biosimilar of Remicade Revenue by Country (2023-2028) & (USD Million) Table 99. Europe Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million) Table 100. Europe Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million) Table 101. Europe Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million) Table 102. Europe Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million) Table 103. Europe Biosimilar of Remicade Revenue by Country (2017-2022) & (USD Million) Table 104. Europe Biosimilar of Remicade Revenue by Country (2023-2028) & (USD Million) Table 105. Asia-Pacific Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million) Table 106. Asia-Pacific Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million) Table 107. Asia-Pacific Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million) Table 108. Asia-Pacific Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million) Table 109. Asia-Pacific Biosimilar of Remicade Revenue by Region (2017-2022) & (USD Million) Table 110. Asia-Pacific Biosimilar of Remicade Revenue by Region (2023-2028) & (USD Million) Table 111. South America Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million) Table 112. South America Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million) Table 113. South America Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million) Table 114. South America Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million) Table 115. South America Biosimilar of Remicade Revenue by Country (2017-2022) & (USD Million) Table 116. South America Biosimilar of Remicade Revenue by Country (2023-2028) & (USD Million) Table 117. Middle East & Africa Biosimilar of Remicade Revenue by Type (2017-2022) & (USD Million) Table 118. Middle East & Africa Biosimilar of Remicade Revenue by Type (2023-2028) & (USD Million) Table 119. Middle East & Africa Biosimilar of Remicade Revenue by Application (2017-2022) & (USD Million) Table 120. Middle East & Africa Biosimilar of Remicade Revenue by Application (2023-2028) & (USD Million) Table 121. Middle East & Africa Biosimilar of Remicade Revenue by Country (2017-2022) & (USD Million) Table 122. Middle East & Africa Biosimilar of Remicade Revenue by Country (2023-2028) & (USD Million) List of Figures Figure 1. Biosimilar of Remicade Picture Figure 2. Global Biosimilar of Remicade Revenue Market Share by Type in 2021 Figure 3. Monoclonal Antibodies Figure 4. Interferon Figure 5. Erythropoietin Figure 6. Insulin Figure 7. Vaccines Figure 8. Other Figure 9. Biosimilar of Remicade Revenue Market Share by Application in 2021 Figure 10. Tumor Picture Figure 11. Diabetes Picture Figure 12. Cardiovascular Picture Figure 13. Hemophilia Picture Figure 14. Other Picture Figure 15. Global Biosimilar of Remicade Market Size, (USD Million): 2017 VS 2021 VS 2028 Figure 16. Global Biosimilar of Remicade Revenue and Forecast (2017-2028) & (USD Million) Figure 17. Global Biosimilar of Remicade Revenue Market Share by Region (2017-2028) Figure 18. Global Biosimilar of Remicade Revenue Market Share by Region in 2021 Figure 19. North America Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028) Figure 20. Europe Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028) Figure 21. Asia-Pacific Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028) Figure 22. South America Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028) Figure 23. Middle East and Africa Biosimilar of Remicade Revenue (USD Million) and Growth Rate (2017-2028) Figure 24. Biosimilar of Remicade Market Drivers Figure 25. Biosimilar of Remicade Market Restraints Figure 26. Biosimilar of Remicade Market Trends Figure 27. Roche Recent Developments and Future Plans Figure 28. Amgen Recent Developments and Future Plans Figure 29. AbbVie Recent Developments and Future Plans Figure 30. Sanofi-Aventis Recent Developments and Future Plans Figure 31. Johnson & Johnson Recent Developments and Future Plans Figure 32. Pfizer Recent Developments and Future Plans Figure 33. Novo Nordisk Recent Developments and Future Plans Figure 34. Eli Lilly Recent Developments and Future Plans Figure 35. Novartis Recent Developments and Future Plans Figure 36. Merck Recent Developments and Future Plans Figure 37. 3sbio Recent Developments and Future Plans Figure 38. Changchun High Tech Recent Developments and Future Plans Figure 39. CP Guojian Recent Developments and Future Plans Figure 40. Biotech Recent Developments and Future Plans Figure 41. Gelgen Recent Developments and Future Plans Figure 42. Innovent Recent Developments and Future Plans Figure 43. Dong Bao Recent Developments and Future Plans Figure 44. Ganlee Recent Developments and Future Plans Figure 45. United Laboratories Recent Developments and Future Plans Figure 46. Global Biosimilar of Remicade Revenue Share by Players in 2021 Figure 47. Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021 Figure 48. Global Top 3 Players Biosimilar of Remicade Revenue Market Share in 2021 Figure 49. Global Top 10 Players Biosimilar of Remicade Revenue Market Share in 2021 Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022) Figure 51. Global Biosimilar of Remicade Revenue Share by Type in 2021 Figure 52. Global Biosimilar of Remicade Market Share Forecast by Type (2023-2028) Figure 53. Global Biosimilar of Remicade Revenue Share by Application in 2021 Figure 54. Global Biosimilar of Remicade Market Share Forecast by Application (2023-2028) Figure 55. North America Biosimilar of Remicade Sales Market Share by Type (2017-2028) Figure 56. North America Biosimilar of Remicade Sales Market Share by Application (2017-2028) Figure 57. North America Biosimilar of Remicade Revenue Market Share by Country (2017-2028) Figure 58. United States Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. Canada Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Mexico Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Europe Biosimilar of Remicade Sales Market Share by Type (2017-2028) Figure 62. Europe Biosimilar of Remicade Sales Market Share by Application (2017-2028) Figure 63. Europe Biosimilar of Remicade Revenue Market Share by Country (2017-2028) Figure 64. Germany Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 65. France Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 66. United Kingdom Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. Russia Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 68. Italy Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 69. Asia-Pacific Biosimilar of Remicade Sales Market Share by Type (2017-2028) Figure 70. Asia-Pacific Biosimilar of Remicade Sales Market Share by Application (2017-2028) Figure 71. Asia-Pacific Biosimilar of Remicade Revenue Market Share by Region (2017-2028) Figure 72. China Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 73. Japan Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 74. South Korea Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. India Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 76. Southeast Asia Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 77. Australia Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 78. South America Biosimilar of Remicade Sales Market Share by Type (2017-2028) Figure 79. South America Biosimilar of Remicade Sales Market Share by Application (2017-2028) Figure 80. South America Biosimilar of Remicade Revenue Market Share by Country (2017-2028) Figure 81. Brazil Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 82. Argentina Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 83. Middle East and Africa Biosimilar of Remicade Sales Market Share by Type (2017-2028) Figure 84. Middle East and Africa Biosimilar of Remicade Sales Market Share by Application (2017-2028) Figure 85. Middle East and Africa Biosimilar of Remicade Revenue Market Share by Country (2017-2028) Figure 86. Turkey Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 87. Saudi Arabia Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 88. UAE Biosimilar of Remicade Revenue and Growth Rate (2017-2028) & (USD Million) Figure 89. Methodology Figure 90. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us